|
||
ARTICLE |
Correspondence to Mark T. Nelson: Mark.Nelson{at}uvm.edu
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Activation of metabotropic glutamate receptors (mGluRs) located on astrocytic projections that surround synapses of glutamatergic neurons results in an increase in astrocytic [Ca2+]i that propagates through astrocytic processes, ultimately resulting in a [Ca2+]i increase in the endfoot (Cornell-Bell et al., 1990; Zonta et al., 2003
). In addition to signaling from presynaptic neurons, local interneurons that innervate arterioles also make extensive contact with endfeet (Hamel, 2006
); however, it is unclear whether cortical astrocytes can respond to stimuli derived from interneurons. Ca2+ release through both inositol 1,4,5-trisphosphate (InsP3) receptors (InsP3Rs) and ryanodine receptors (RyRs) has been implicated in the generation of astrocytic Ca2+ signals (Golovina and Blaustein, 1997
, 2000
; Verkhratsky et al., 1998
; Beck et al., 2004
; Perea and Araque, 2005
). Golovina and Blaustein (1997
, 2000
) elegantly demonstrated the presence of spatially and functionally distinct InsP3 and ryanodine/caffeine-sensitive Ca2+ stores in primary cultured astrocytes, based on fluorescence measurements of endoplasmic reticulum Ca2+ load and changes in [Ca2+]i in response to agonist stimulation. Interestingly, these authors noted little overlap between regions of the endoplasmic reticulum that were sensitive to InsP3 and those sensitive to caffeine/ryanodine, indicating that regional specificity likely exists in the generation of astrocytic [Ca2+]i signals.
Several studies have shown that neuronal activityinduced increases in astrocytic [Ca2+]i can occur within spatially localized regions of astrocytic processes. Grosche et al. (1999)
identified specific regions along processes of Bergmann glia, termed glial microdomains, in which spatially restricted [Ca2+]i increases were generated in response to stimulation of parallel fibers in the cerebellum. In addition, Araque et al. (2002)
showed that hippocampal astrocytes in situ exhibit spatially defined regions of elevated [Ca2+]i in response to stimulation of cholinergic neurons. Although these studies investigated [Ca2+]i signals in nonperivascular astrocytic processes, the generation of local and spatially restricted [Ca2+]i increases is highly relevant in perivascular processes, from which Ca2+-dependent vasoactive factors are likely to be released into the endfoot-arteriolar space, rather than into the brain parenchyma.
One of the functional outcomes of astrocytic [Ca2+]i signaling is the regulation of cerebral arteriole diameter to modulate local cerebral blood flow. Astrocytes and cerebral arterioles form the functional gliovascular unit, with astrocytic endfeet and perivascular processes completely encasing the arterioles (Simard et al., 2003
). The intimate association of endfeet and arteriolar SMCs (
20 nm between endfoot and SMCs; Nagelhus et al., 2004
) suggests that signaling mechanisms in endfeet are ideally positioned to exert profound changes on arteriolar function. Indeed, elevation of [Ca2+]i within individual endfeet in vivo, through photolysis of caged Ca2+, induces vasodilation of adjacent arterioles (Takano et al., 2006
). However, similar studies in brain slices suggest that elevation of endfoot [Ca2+]i induces vasoconstriction of adjacent arterioles (Mulligan and MacVicar, 2004
). Although these studies establish endfoot [Ca2+]i as an essential regulator of vascular function, the mechanisms by which endfoot [Ca2+]i signals arise and the spatiotemporal properties of these signals are not known. This knowledge is critical to a thorough understanding of neurovascular coupling.
We hypothesize that astrocytic endfeet possess the necessary Ca2+ signaling machinery to generate [Ca2+]i increases independent of the remainder of the astrocyte and that these [Ca2+]i signals are generated primarily by Ca2+ release through endfoot resident InsP3R. In addition, we suggest that endfoot [Ca2+]i signals should be highly dynamic and thus capable of rapidly exerting local control over Ca2+-dependent signaling processes within endfeet. Indeed, our findings indicate that complex and dynamic [Ca2+]i signals are generated within astrocytic endfeet and result from InsP3-mediated Ca2+ release events within endfeet. Furthermore, release of InsP3 within a single endfoot is capable of inducing local vasodilation of an adjacent arteriole, supporting the concept that endfeet function as individual "vasoregulatory units" in the brain.
| MATERIALS AND METHODS |
|---|
|
|
|---|
200-µm-thick coronal slices. Slices were placed into 22°C aCSF equilibrated with 95% O2/5% CO2, pH
7.45. aCSF contained 125 mM NaCl, 3 mM KCl, 26 mM NaHCO3, 1.25 mM NaH2PO4, 2 mM CaCl2, 1 mM MgCl2, 10 mM glucose, and 400 µM L-ascorbic acid, added to reduce cell swelling associated with oxidative stress. All experiments were conducted at 35°C except those in Fig. 3, which were performed at 22°C to minimize the potential for extrusion of caged InsP3 from astrocytes.
[Ca21]i Imaging and Arteriolar Diameter Measurements within Cortical Slices
[Ca2+]i imaging was performed using either a Solamere scanning confocal unit (QLC 100) and high-sensitivity, high-resolution intensified charge-coupled device camera (Stanford Photonics) attached to an upright microscope (E600FN; Nikon) with a 60x water-immersion objective (NA 1.0) or a Noran Oz laser scanning confocal attached to an inverted microscope (TE2000; Nikon) with a 60x oil-immersion objective. Slices were loaded with 10 µM fluo-4 AM (or fluo-5F in Fig. 4; Invitrogen) and 2.5 µg/ml pluronic acid in aCSF for 90 min at 22°C. Under these loading conditions, AM dyes load primarily into astrocytes, with little loading into SMCs and no loading into arteriolar endothelial cells (Zonta et al., 2003
; Takano et al., 2006
; Wang et al., 2006
). Dye was excited at 488 nm with a krypton/argon laser, and fluorescence emission was collected above 495 nm. Images were acquired at 1560 frames/s. Fractional fluorescence (F/Fo) was determined by dividing the fluorescence intensity (F) within a region of interest by a mean fluorescence value (Fo) determined from 50 images before stimulation. For arteriole diameter measurements within cortical slices, infrared differential interference contrast images were acquired at
5 frames/s with a charge-coupled device camera (Hamamatsu). Arteriolar internal (luminal) diameter was determined from the distance between two fixed points across the arteriole and directly adjacent to the identified endfoot. In experiments where arteriolar diameter was measured (presented in Figs. 1 and 5) the thromboxane A2 receptor agonist 9, 11-Dideoxy-11
, 9
-epoxymethanoprostaglandin F2
(U46619; 100 nM) was included to maintain vascular tone throughout the course of the experiment, such that vasodilation and vasoconstriction could be measured (Brown et al., 2002
). The diameter recordings in Fig. 5 were performed in cortical brain slices from 2135-d-old Sprague Dawley rats, as measurements of diameter changes in rats are more accurate and reproducible because of the larger diameter and, thus, larger absolute magnitude of the diameter changes of arterioles in the rat versus mouse.
Flash Photolysis of Caged InsP3 and Electrical Stimulation of Neuronal Activity
For experiments using caged InsP3 to induce endfoot [Ca2+]i increases, slices were loaded with 2 µM iso-Ins(1,4,5)P3-PM (Axxora) along with 10 µM fluo-4 AM (Invitrogen) and 2.5 µg/ml pluronic acid in aCSF for 90 min at 22°C. Flash photolysis was achieved by means of a xenon arc lampbased UV flash unit (Rapp OptoElectronics) and custom-designed condenser (TILL Photonics) with adjustable spot diameter restricted to an
23-µm region of the slice wholly contained within an endfoot and calibrated using fluorescent microspheres of varying diameter. The intensity of the UV flash was adjusted to induce endfoot delimited [Ca2+]i increases. The mean duration of an uncaging pulse was
1 ms. Electrical field stimulation (EFS) was used to stimulate neuronal activity by applying a 50-Hz alternating square pulse of 0.3-ms duration for 35 s (80100 V) via a pair of platinum wires placed parallel to the brain slice. The elevation of astrocytic [Ca2+]i by EFS was inhibited by tetrodotoxin (Filosa et al., 2004
), a blocker of voltage-dependent sodium channels, indicating neuronal involvement.
Data Analysis
Data were analyzed using the appropriate t test and were considered statistically significant when P < 0.05. All data are expressed as mean ± SEM. [Ca2+]i imaging and arteriole diameter data were analyzed using custom-designed software created by A. Bonev.
Reagents
Caged InsP3 (iso-InsP3-PM) was obtained from Axxora. The thromboxane A2 receptor agonist 9, 11-Dideoxy-11
, 9
-epoxymethanoprostaglandin F2
(U46619), xestospongin C, and U73122 were obtained from Calbiochem. Ryanodine was obtained from LC Labs and Calbiochem. Fluo-4 AM, Fluo-5F AM, and pluronic acid were obtained from Invitrogen. Cyclopiazonic acid (CPA), caffeine, and all other chemicals were obtained from Sigma-Aldrich.
Online Supplemental Material
The online supplemental material (Fig. S1 and Videos 1 and 2) contain additional examples of the lack of effect of caffeine on astrocytic [Ca2+]i signals and videos of the recordings presented in Fig. 1 and Fig. 4 A. Online supplemental material is available at http://www.jgp.org/cgi/content/full/jgp.200609650/DC1.
| RESULTS |
|---|
|
|
|---|
Neuronally Evoked [Ca2+]i Increases in Astrocytic Endfeet In Situ Involve Ca2+ Release from InsP3R
[Ca2+]i increases in astrocytic endfeet have been identified as critical mediators of neurovascular coupling. To investigate this further, endfoot [Ca2+]i and arteriolar diameter changes were monitored simultaneously in mouse cortical brain slices loaded with the Ca2+-sensitive dye fluo-4 AM. Neuronal synaptic activity was induced through EFS, and the effect of this activity on endfoot [Ca2+]i and arteriolar diameter was measured. As illustrated in Fig. 1, EFS induced rapid increases in endfoot [Ca2+]i, which were followed by dilation of the adjacent arteriole under conditions in which arterioles were preconstricted with 100 nM of the thromboxane A2 receptor agonist U46619 to mimic vascular tone found in vivo (Brown et al., 2002
).
It was found that endfoot [Ca2+]i increased first, followed closely by dilation of the arteriole, which returned to prestimulus diameter as endfoot [Ca2+]i decreased to basal levels (Video 1, available at http://www.jgp.org/cgi/content/full/jgp.200609650/DC1). In
30% of experiments, we observed that the soma and endfoot of a particular astrocyte were aligned in the same focal plane; thus, the astrocytic [Ca2+]i increase induced by EFS could be visualized in both the soma and endfoot in these instances. These findings are in agreement with several published studies implicating astrocytes in the control of the cerebral vasculature (Zonta et al., 2003
; Filosa et al., 2004
, 2006
; Metea and Newman, 2006
).
|
|
Spatially Restricted Photolysis of InsP3 within Endfeet Supports a Role for Endfoot Localized InsP3R, but Not RYR, in Generating Endfoot [Ca2+]i Increases
The experiments presented in Fig. 2 rely on neuronal activity to induce increases in astrocytic endfoot [Ca2+]i. This process thus requires the generation of a [Ca2+]i increase in the astrocytic cell body followed by an increase in the endfoot, and as such, it is not possible to differentiate whether the [Ca2+]i increase occurs as a result of diffusion of Ca2+ from the astrocytic cell body or as a result of Ca2+ released from InsP3R within the endfoot itself. In addition, xestospongin C, U73122, and CPA could potentially alter neuronal [Ca2+]i signaling, such that the efficacy of EFS is compromised. To overcome these potential complications, as well as to directly probe the [Ca2+]i signaling components resident within endfeet, we used spatially restricted photolysis of caged InsP3 to release InsP3 directly within endfeet. This technique allows us to elicit Ca2+ release from InsP3R located within endfeet (assuming InsP3Rs are expressed in endfeet) without involving the remainder of the astrocyte or neurons.
As illustrated in Fig. 3 D, endfeet abutting arterioles were identified and aligned to a previously calibrated spot within the imaging window, into which UV light was focused (see Materials and methods).
The diameter of the UV spot was adjusted between 2 and 3 µm (Fig. 3 D), a diameter sufficiently small to be wholly encompassed by an endfoot (mean visible dimensions of endfeet in uncaging experiments = 9 x 3 µm; n = 21). In addition, the intensity of UV light was adjusted such that endfoot delimited [Ca2+]i increases were elicited. Similar to astrocytic [Ca2+]i increases induced by EFS, endfoot [Ca2+]i increases induced by flash photolysis of caged InsP3 were consistent in terms of the peak [Ca2+]i increase elicited and the latency of the response over multiple uncaging events (Fig. 3 A). The peak [Ca2+]i increase elicited by the second photorelease of InsP3, which also served as the time-matched control for experiments conducted in the presence of pharmacological inhibitors, was 69.5 ± 7.5% of the first response (Fig. 3 A; n = 10). In addition, the peak [Ca2+]i increases elicited by EFS and uncaging did not differ significantly (first response peak F/Fo for EFS = 1.99 ± 0.12 vs. 2.16 ± 0.15 from uncaging; 15
n
20; P = 0.4). Importantly, we saw no evidence of the InsP3-induced [Ca2+]i increase spreading out of the endfoot, such as a secondary [Ca2+]i increase in the cell body (23 experiments), and no [Ca2+]i increase was generated by the UV flash in the absence of caged InsP3 (n = 11). Endfoot [Ca2+]i increases induced by uncaging occurred more rapidly than EFS-induced responses (1.00 ± 0.17 s from the time of uncaging to 25% peak [Ca2+]i increase vs. 2.3 ± 0.2 s for EFS; n = 10; P < 0.0001) and were not significantly different between the first and second uncaging events (P = 0.2; n = 8 pairs). These findings suggest that [Ca2+]i increases in astrocytic endfeet are generated as a result of regenerative Ca2+ release from InsP3Rs located within the endfoot.
|
n
10; P = 0.64). Because the effects of ryanodine on RYR are use dependent, such that ryanodine only binds to the open channel (Zucchi and Ronca-Testoni, 1997
n
10; P < 0.0001). These findings suggest that endfeet possess the Ca2+ release machinery, in the form of InsP3R, to generate [Ca2+]i signals independently of the remainder of the astrocyte. These regenerative Ca2+ release signals likely underlie the generation of vasoactive substances involved in neurovascular coupling.
Perivascular Astrocytic Endfeet and Processes Generate Spatially Heterogeneous [Ca2+]i Signals
Traditionally, astrocytic [Ca2+]i increases involved in neuronastrocyteblood vessel signaling have been recognized as a wave that "travels" to the endfoot. Only a few studies have investigated the possibility that astrocytes contain spatially heterogeneous [Ca2+]i signaling domains, and no study to date has investigated the [Ca2+]i signaling dynamics of astrocytic endfeet. Thus, we investigated the spatial properties of neuronally mediated increases in [Ca2+]i in perivascular astrocytic endfeet and processes.
Perivascular astrocytic [Ca2+]i signals generated in response to neuronal activity exhibited nonhomogeneous complex behavior as observed by the following: (1) the presence of multiple distinct propagating [Ca2+]i waves within individual endfeet and perivascular processes; (2) heterogeneity in the [Ca2+]i increase in both endfeet and perivascular processes; (3) the presence of persistently elevated, spatially restricted regions of [Ca2+]i in endfoot regions directly apposed to arterioles; and (4) the presence of local Ca2+ release sites within endfeet. In the example shown in Fig. 4 A (also Video 2, available at http://www.jgp.org/cgi/content/full/jgp.200609650/DC1), in response to EFS, a propagating [Ca2+]i wave traveled down one perivascular process toward the endfoot (shown by arrow in 1-s snapshot). The mean rate of wave propagation in perivascular astrocytic processes studied in these experiments was 12.7 ± 0.8 µm/s (n = 3). This [Ca2+]i wave invaded the endfoot, which generated its own [Ca2+]i wave traveling perpendicular to the [Ca2+]i wave in the process (shown by arrow in 3-s snapshot). Regions of elevated [Ca2+]i within the endfoot were clearly visible before invasion of the endfoot by the [Ca2+]i wave (visible in 1-s snapshot), suggesting the presence of active Ca2+ release within the endfoot. In further support of active Ca2+ release within the endfoot, a spatially restricted region of elevated [Ca2+]i existed within the endfoot after decay of [Ca2+]i back to basal levels in the processes and most of the endfoot (15-s snapshot). On average, these regions of elevated [Ca2+]i occupied 37.7 ± 8.7% of the visible area of the endfoot 15 s after EFS (n = 3) and decayed back to basal levels within 45 s.
|
2 s after appearance of the initial [Ca2+]i increase), the polarity of the response ([Ca2+]i increase initiates and ends at the same location), and the lack of a ryanodine-sensitive release component are consistent with the assertion that endfoot [Ca2+]i increases are driven by Ca2+ release through InsP3Rs that are likely organized into heterogeneous Ca2+ release sites within endfeet.
Ca2+ Release from Endfoot InsP3R Is Sufficient to Activate Signaling Mechanisms that Dilate Adjacent Arterioles
The organization of the [Ca2+]i signaling machinery within astrocytic endfeet likely underlies the ability of astrocytes to rapidly modulate local cerebral blood flow in response to neuronal activity. To determine whether [Ca2+]i signals that are spatially restricted to a single endfoot and occur as a result of Ca2+ release through InsP3R are coupled to a vascular response, changes in the diameter of adjacent arterioles in response to the photolysis of caged InsP3 in endfeet were measured in brain slices. As shown in Fig. 5, photolysis of caged InsP3 in a single endfoot abutting an arteriole generated vasodilation of the arteriole, which remained localized to the region of the vessel in the immediate vicinity of the endfoot.
As noted previously, we saw no evidence of a retrograde increase in [Ca2+]i in the astrocytic cell body. In response to these endfoot delimited [Ca2+]i signals, arterioles dilated to an average of 118 ± 6% of prestimulus diameter (n = 6; P = 0.03), and this dilation was restricted to an
30-µm length of the vessel. This InsP3-induced vasodilation occurred rapidly, with the dilation reaching 50% of the maximum within 1.6 ± 0.3 s (n = 4) of the uncaging event. The rapidity with which the vasodilation occurred after uncaging correlates well with the latency in the endfoot [Ca2+]i increase noted previously (1.00 ± 0.17 s from time of uncaging to 25% peak [Ca2+]i increase) and suggests that the vasodilation is indeed induced by the rise in endfoot [Ca2+]i that occurs as a result of activation of endfoot InsP3R. Overall, these findings support a model of neurovascular coupling in which highly dynamic, InsP3-mediated [Ca2+]i signaling events in astrocytic endfeet exert local control over vascular function.
|
-aminobutyric acid (GABA) interneuron can dilate or constrict an adjacent arteriole, depending on whether vasoactive intestinal peptide (VIP) or somatostatin (SOM) are released from the interneuron. Interestingly, these neurons also make extensive contact with endfoot processes (Hamel, 2006
To investigate the effect of putative interneuron neurotransmitters on endfoot [Ca2+]i in cortical astrocytes, fluo-4 AM loaded cortical brain slices were stimulated with either SOM or VIP in the presence of 1 µM tetrodotoxin to limit neuronal activity, and the resultant effect of agonist treatment on endfoot [Ca2+]i monitored with confocal microscopy (Fig. 6).
Rapid local application (pipette placed within
30 µm of endfoot) of SOM and VIP (1 µM each) in the vicinity of an endfoot induced large amplitude increases in astrocytic endfoot [Ca2+]i (mean peak [Ca2+]i increase, 2.27 ± 0.21 F/Fo units for SOM and 2.45 ± 0.46 units for VIP; 5
n
7). 1 µM neuropeptide Y was less effective in eliciting endfoot [Ca2+]i increases, with small (<1.4 F/Fo units) increases detected in only two out of five endfeet studied. These findings support the concept that endfoot [Ca2+]i changes can be elicited by neurotransmitters released from interneurons in contact with endfeet and illuminate a possible additional level of control over the generation of endfoot [Ca2+]i signals.
|
| DISCUSSION |
|---|
|
|
|---|
The following observations suggest that endfoot [Ca2+]i increases are highly dynamic and heterogeneous events driven primarily by Ca2+ release from InsP3R expressed in endfeet: (1) the peak amplitude of EFS-induced [Ca2+]i increases was decreased by InsP3R and phospholipase C inhibition and responses were virtually eliminated by depletion of the intracellular Ca2+ store; (2) photolysis of caged InsP3 within endfeet generated an endfoot delimited [Ca2+]i increase, with no evidence of [Ca2+]i elevation in regions of the astrocyte outside the endfoot; (3) InsP3 and EFS-induced endfoot [Ca2+]i increases were not altered by block of RYR; and (4) endfeet and perivascular processes generated nonuniform increases in [Ca2+]i and multiple distinct [Ca2+]i waves in response to neuronal activity. Furthermore, the current findings are the first to show that [Ca2+]i increases that are spatially restricted to endfeet and generated by Ca2+ release through InsP3R are sufficient to induce vasodilation of adjacent arterioles. In addition, we find no evidence for a contribution of Ca2+-induced Ca2+ release through RYR in the generation of endfoot [Ca2+]i increases in response to neuronal activity or photolysis of caged InsP3. Our findings do not rule out the possibility that RYRs contribute to the astrocytic [Ca2+]i signal in the soma. In addition, it is possible that RYRs may generate Ca2+ release events that affect local physiological responses without contributing significantly to global endfoot [Ca2+]i changes. Several studies have shown that [Ca2+]i increases in the astrocytic soma or processes can be blocked by inhibition of the InsP3phospholipase C pathway and induced by photolysis of caged InsP3 (Golovina and Blaustein, 1997
, 2000
; Beck et al., 2004
; Fiacco and McCarthy, 2004
); the current results extend these findings to create an understanding of the processes underlying the generation of [Ca2+]i signals in endfeet.
Spatial heterogeneity in astrocytic [Ca2+]i signaling has been observed in primary cultured rat cortical astrocytes (Golovina and Blaustein, 1997
) and Bergmann glial cells (Grosche et al., 1999
) and rat hippocampal astrocytes (Araque et al., 2002
) in situ. However, no study has yet investigated the spatial characteristics of endfoot [Ca2+]i signals. This information is vital because the spatial organization of endfoot [Ca2+]i signals likely underlies the specific activation of Ca2+-sensitive targets, such as large conductance Ca2+-sensitive potassium (BK) channels (Price et al., 2002
; Filosa et al., 2006
), which require micromolar [Ca2+]i for activation (Perez et al., 2001
). Based on observations of regions of local Ca2+ release within individual endfeet (Fig. 4), as well as regions of persistently elevated [Ca2+]i within a fraction of the endfoot volume (Fig. 4 A), our findings support the assertion that local [Ca2+]i signaling domains are present in endfeet and are likely due to clustering of release channels within endfeet. Although the exact localization of Ca2+-sensitive proteins, such as BK channels or phospholipase A2, in the endfeet is not known, it is likely that these proteins are organized along endfoot membranes in contact with arterioles, an arrangement that would allow for privileged communication between endfeet and the vasculature, as has been argued for the expression of aquaporin 4 (Simard and Nedergaard, 2004
). Thus, the spatial organization of local [Ca2+]i signals in endfeet, coupled with the polarized expression of effector proteins (Price et al., 2002
), likely underlies the rapid and specific activation of Ca2+-sensitive signaling processes involved in modulating arteriolar diameter.
In the cortex, astrocytic [Ca2+]i increases generated in response to neuronal activity typically arise from the release of glutamate from presynaptic neurons and activation of mGluR on astrocytes (Kirischuk et al., 1999
; Zonta et al., 2003
). In addition, ionotropic NMDA, AMPA (
-amino-3-hydroxy-5-methylisoxazole-4-propionic acid), and kainate receptors expressed by astrocytes may allow for the influx of Ca2+ in response to glutamate binding (Clark and Barbour, 1997
; Lalo et al., 2006
). Our results illustrate an additional mechanism by which [Ca2+]i increases can arise in cortical astrocytes, namely, through release of neurotransmitters from
-aminobutyric acid (GABA) interneurons in contact with endfeet. Specifically, we tested the neurotransmitters SOM and VIP, as these have been shown to induce vascular responses when perfused onto cerebral arterioles in brain slices and are present in interneurons that induce changes in arteriolar diameter when depolarized (Cauli et al., 2004
). These authors showed opposing effects of these neurotransmitters on cerebral arterioles, with VIP inducing dilation and SOM inducing constriction of vessels. Interestingly, elevation of endfoot [Ca2+]i has also been shown to be capable of inducing both vasodilation (Zonta et al., 2003
; Filosa et al., 2006
; Metea and Newman, 2006
; Takano et al., 2006
) and vasoconstriction (Mulligan and MacVicar, 2004
) of cerebral arterioles. Although the work of Cauli et al. (2004)
clearly illustrates a direct effect of interneurons on arterioles, the current findings suggest that the effects of direct vascular innervation from interneurons might be fine-tuned by additional signals from endfeet, with the interaction of both signaling mechanisms eliciting specific degrees and/or periods of vascular diameter change.
Neurovascular coupling must be rapid and spatially localized, such that an increase in blood flow is delivered to the site of increased metabolic demand (Iadecola, 2004
). Thus, mechanisms must exist to spatially restrict increases in blood flow in response to neuronal activity. Based on the local vasodilating influence of InsP3-induced [Ca2+]i increases in individual astrocytic endfeet (Fig. 5), our findings suggest that individual endfeet exert control over the regulation of arteriolar diameter within a spatially restricted region of the arteriole that extends only a short distance from the main endfoot process. This finding implies that the extent of spread of the increase in blood flow will be determined by the number of endfeet activated, which in turn is a function of the extent of neuronal activity. Thus, endfeet serve as individual "vasoregulatory units," the sum total of which defines the region in which blood flow changes are generated.
Our findings suggest that astrocytic endfeet serve as active participants in the process of neurovascular coupling and are capable of generating dynamic and spatially specific [Ca2+]i signals and exerting local control over arteriolar diameter. These findings further illuminate the critical role that astrocytes serve in coupling neuronal activity to changes in local cerebral blood flow and highlight the ability of endfoot [Ca2+]i signals to specifically activate Ca2+-sensitive processes that ultimately lead to spatially restricted alterations in cerebral arteriolar diameter.
| ACKNOWLEDGMENTS |
|---|
This work was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health through a postdoctoral fellowship to S.V. Straub (HL83768), a postdoctoral training grant to M.K. Wilkerson (HL07944), and a grant to M.T. Nelson (HL44455), and by the Totman Trust for Medical Research.
Olaf S. Andersen served as editor.
Submitted: 14 August 2006
Accepted: 2 November 2006
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
|